These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2538518)

  • 1. Primary study of attenuated live hepatitis A vaccine (H2 strain) in humans.
    Mao JS; Dong DX; Zhang HY; Chen NL; Zhang XY; Huang HY; Xie RY; Zhou TJ; Wan ZJ; Wang YZ
    J Infect Dis; 1989 Apr; 159(4):621-4. PubMed ID: 2538518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies of prototype live hepatitis A virus vaccines in primate models.
    Karron RA; Daemer R; Ticehurst J; D'Hondt E; Popper H; Mihalik K; Phillips J; Feinstone S; Purcell RH
    J Infect Dis; 1988 Feb; 157(2):338-45. PubMed ID: 2826614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and immunogenicity of a live attenuated hepatitis A virus vaccine in seronegative volunteers.
    Midthun K; Ellerbeck E; Gershman K; Calandra G; Krah D; McCaughtry M; Nalin D; Provost P
    J Infect Dis; 1991 Apr; 163(4):735-9. PubMed ID: 1849160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and immunogenicity of live attenuated hepatitis A virus vaccine (H2 strain) in humans.
    Ran LA; Wang DZ; Duan QY; Yan TY; Liu QL; Luo YG; Yang DZ; Yang DF; Xiao Z; Xie QJ
    Chin Med J (Engl); 1993 Aug; 106(8):604-7. PubMed ID: 8222910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity trial of inactivated hepatitis A virus vaccine in human volunteers.
    Kusov YuYu ; Elbert LB; Nelga IV; Grishina GK; Dunaevski OA; Kharin NV; Maslov YuN ; Drozdov SG; Balayan MS
    Vaccine; 1991 Aug; 9(8):540-1. PubMed ID: 1663301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experimental in vivo passage of H2 strain of live attenuated vaccine of hepatitis A in common marmosets].
    Huang X; Lian Y; Wang Q
    Zhonghua Yu Fang Yi Xue Za Zhi; 1997 Sep; 31(5):260-2. PubMed ID: 9812599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and laboratory observations following oral or intramuscular administration of a live attenuated hepatitis A vaccine candidate.
    Sjogren MH; Purcell RH; McKee K; Binn L; Macarthy P; Ticehurst J; Feinstone S; Caudill J; See A; Hoke C
    Vaccine; 1992; 10 Suppl 1():S135-7. PubMed ID: 1335645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactogenicity and immunogenicity of inactivated hepatitis A vaccines.
    Just M; Berger R
    Vaccine; 1992; 10 Suppl 1():S110-3. PubMed ID: 1362031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunological effects of live attenuated hepatitis A vaccine].
    Cheng NL
    Zhonghua Yi Xue Za Zhi; 1992 Oct; 72(10):581-3, 638. PubMed ID: 1338501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An inactivated hepatitis A viral vaccine of cell culture origin.
    Provost PJ; Hughes JV; Miller WJ; Giesa PA; Banker FS; Emini EA
    J Med Virol; 1986 May; 19(1):23-31. PubMed ID: 3009703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of a hepatitis A virus vaccine.
    Flehmig B; Haage A; Pfisterer M
    J Med Virol; 1987 May; 22(1):7-16. PubMed ID: 3035082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Safety observation of attenuated live hepatitis B vaccine (H2 strain) in humans].
    Zhang S
    Zhonghua Yi Xue Za Zhi; 1990 Dec; 70(12):682-4, 48. PubMed ID: 1963372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and immunogenicity of hepatitis A vaccine in healthy adult volunteers.
    Horng YC; Chang MH; Lee CY; Safary A; Andre FE; Chen DS
    J Gastroenterol Hepatol; 1993; 8(4):338-41. PubMed ID: 8397010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Observation of live, attenuated hepatitis A vaccines in humans].
    Hu MD
    Zhonghua Yu Fang Yi Xue Za Zhi; 1993 Mar; 27(2):65-8. PubMed ID: 8394801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous vaccination for hepatitis A and B.
    Flehmig B; Heinricy U; Pfisterer M
    J Infect Dis; 1990 May; 161(5):865-8. PubMed ID: 2157770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The trial preparation of attenuated live hepatitis A vaccine].
    Dong DX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1989 Feb; 11(1):1-6. PubMed ID: 2548744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immune response to different doses of inactivated hepatitis A vaccine.
    Jilg W; Bittner R; Schätzl H; Rasshofer R; Schmidt M; Deinhardt F
    J Hepatol; 1993; 18 Suppl 2():S38-40. PubMed ID: 8182271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further evaluation of the safety and protective efficacy of live attenuated hepatitis A vaccine (H2-strain) in humans.
    Mao JS; Chai SA; Xie RY; Chen NL; Jiang Q; Zhu XZ; Zhang SY; Huang HY; Mao HW; Bao XN; Liu CJ
    Vaccine; 1997 Jun; 15(9):944-7. PubMed ID: 9261939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further evaluation of a live hepatitis A vaccine in marmosets.
    Provost PJ; Banker FS; Wadsworth CW; Krah DL
    J Med Virol; 1991 Aug; 34(4):227-31. PubMed ID: 1658214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A trial of the reactogenicity and immunogenicity of an inactivated hepatitis A vaccine.
    Green MS; Cohen D; Lerman Y; Sjogren M; Binn LN; Zur S; Slepon R; Robin G; Hoke C; Bancroft W
    Isr J Med Sci; 1994; 30(5-6):485-8. PubMed ID: 8034508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.